Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / COM SHS
-
Total 13F shares
-
204,827
-
Share change
-
+94,908
-
Total reported value
-
$1,961,849
-
Price per share
-
$9.58
-
Number of holders
-
20
-
Value change
-
+$906,288
-
Number of buys
-
14
-
Number of sells
-
3
Institutional Holders of Serina Therapeutics, Inc. - COM SHS (SER) as of Q2 2024
As of 30 Jun 2024,
Serina Therapeutics, Inc. - COM SHS (SER) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
204,827 shares.
The largest 10 holders included
BROADWOOD CAPITAL INC, Waverly Advisors, LLC, GEODE CAPITAL MANAGEMENT, LLC, HighTower Advisors, LLC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., Tower Research Capital LLC (TRC), UBS Group AG, and BANK OF AMERICA CORP /DE/.
This page lists
20
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.